Skip to Main Content

Paper Details

Trends in Utilization and Cost of Low-Density Lipoprotein Cholesterol-Lowering Therapies Among Medicare Beneficiaries: An Analysis From the Medicare Part D Database.
JAMA Cardiol
11
2021
Cholesterol, LDL-C, Low-Density Lipoprotein Cholesterol, Low-density lipoprotein cholesterol, PCSK9, Participants, atherosclerotic cardiovascular disease, cholesterol, ezetimibe, proprotein convertase subtilisin/kexin type 9, statin, statins
Author NameAffiliation
Ann Marie NavarDuke Clinical Research Institute
Ann Marie Navar
Gregg C FonarowAhmanson-university of california los angeles Cardiomyopathy Center, university of california los angeles Health, University of California
Gregg C Fonarow
Gregg C FonarowAhmanson-university of california los angeles Cardiomyopathy Center, university of california los angeles Health, University of California
Gregg C Fonarow
  • 1 - 6

Datasets

Release 1.2